Freedom Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Freedom Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,051	Closed	-$333K	–	798
2023 Q1	$333K	Sell	3,051 -4,070	-57%	-$450K	0.04%	522
2022 Q4	$810K	Buy	7,121 +1,081	+18%	+$89.8K	0.09%	285
2022 Q3	$374K	Sell	6,040 -983	-14%	-$68.7K	0.04%	502
2022 Q2	$560K	Buy	7,023 +1,497	+27%	+$142K	0.06%	415
2022 Q1	$581K	Buy	5,526 +312	+6%	+$30.4K	0.05%	431
2021 Q4	$562K	Buy	5,214 +215	+4%	+$23.5K	0.04%	491
2021 Q3	$548K	Sell	4,999 -72	-1%	-$7.47K	0.04%	474
2021 Q2	$475K	Sell	5,071 -617	-11%	-$56.8K	0.04%	554
2021 Q1	$524K	Buy	+5,688	New	+$480K	0.04%	508
2018 Q2	–	Sell	-13,712	Closed	-$195K	–	1197
2018 Q1	$195K	Buy	+13,712	New	+$203K	0.01%	1044
2017 Q3	–	Sell	-13,345	Closed	-$158K	–	1176
2017 Q2	$158K	Buy	13,345 +21	+0.2%	+$261	0.01%	1008
2017 Q1	$197K	Buy	+13,324	New	+$216K	0.01%	971

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Freedom Investment Management's HZNP Position: Q2 2023 in Review

Freedom Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 3,051 shares — an estimated $333K sold.

Freedom Investment Management first reported a position in HZNP in Q1 2017 and held it in 12 quarters. The position peaked at $810K in Q4 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Freedom Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Freedom Investment Management sold 3,051 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $333K.
Freedom Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2017 and held it in 12 quarters.
Freedom Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $810K in Q4 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Freedom Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.